JEFFERSON MEDICAL COLLEGE of 4 ) ooorMO TThHoOmN MaAsS JA EFFERM SON UNI IVERSV ITY IRI ~~Y SuieBrouroghsesiooftneeoofsroms ' [--eis--sisi Direc oo Erman q Novesber 12, 1982 DTHreo.dxitccFaorllaongkpyelpianSretDr.aveinGctreisffith YS2E.0-2p8au-l0,0 MMiinnCeesnottear 55101 Dear Dr.

i Centre Analytical Laboratories, Inc. 0 "504P8honeR:e(s8e1a4r)c2h3D1-i8v0e32 Fax: (814) 23S1-a1t25e3Coolrl(a6g1e4,) 2P3A1-161850810 i EN-5 i Analytical Report i Fluorochemical Characterization of Drinking Water Samples Port St.

e- ` ARNE-0ll6 ACTIVATED SLUDGE RESPIRATION INHIBITION TEST TEST SUBSTANCE Identity: Perfluorooctanesulfonate, DEA salt; may also be referred to as PFOS DEA salt, FC-99, or 3 Sample No. 2. (1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7.7.8,8 8-heptadecafluoro-, compd. with 2,2-iminobis[ethanol] (1:1), CAS # 70225-14-8) R(aepmparrokxism:atTeelsyt 2s5am%plteestissaubmsitxatnucree aofndth7e5te%stwastuebrs)t.anAclevianlwuaetserreported relate to this mixture.

AR126-0161 SUMMARY OF THE EFFECTS OF PFC's ON MITOCHONDRIAL BIOENERGETICS IN VITRO The attached diagram describes the metabolic relationship for the various PFC's that were selected for inclusion in this study.

AttacShtmuednitess taondLeOtttehrertoICn.foArumeartidoanteodn MCearyta1i8n, 2000 AR226 O13 Perfluorooctane Sulfonate-Related Compounds Pertwee AcuteToxicity 1) FAimnearlicRaep,oIrntc,.

@HAZLETON reTy"N \ 016% ) J Z NS i ANALYSIS OF T-5794 IN A CELL PROLIFERATION ASSAY IN RAT LIVER CELLS AR26-0302 [EINAL REPORT AUTHOR Maria A.

"a (&) pry 3 rr AR226 _ 1112 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 ne 21 22 PREVXENTCIoOrSNiUFcBEeSSToTAFNCCIEESS AO MEMORANDUM SUBJECT: Meeting Summary; August 13, 207 EPA/Industry Meeting on PFOA FROM: I Gober" DOfefpiucteoyfDPiorlelcuttoifofonrPRreegvuelnatitoonryanMdanTaogxiecmsent TO: APdFmOiSni,sPtrFaOtAiv,eTReelcoomrerdsF,ilaendARR-e2la2t6ed Chemicals Toxic SuSbtsetvaenJcoehsn,smoent, wthiethAscsoirsptoarnattAedemxienciusttirvaetsorfroofmtsheevOefnficcoemopfanPireevseintnivoonl,vePdeswtiitcihdetsh,e and.

. & a : WN; AR 226 _ 1142 UNITED STATESWEANSVHIINRGOTNOMNE,NTDA.CL.

2pco 3M @-33 SKaatheVriinsePEr.esRiedcentt, PhD. 3nMd ESnuvlilryonSmeervnitcaels Technology gGH-R 1102-00373 LEH - 9B0ui0ldBiunsgh4A2.v3e6n.e36 S Raansr ss me Ge343L CERTIFIED MAIL October 30, 2002 AR 26_ 1/38 Contain NO CB) o 5 Document Processing Center (7407M) OEfPfAiceEaofsPt--olRloutoimon6P4r2e8veAntttin:onSaencdtiToonx8i(ccs) U12S00EPPeAnnsylvania Ave, NW Washington, DC 20460-0001 son =o ih i=S uh 5 `TSCA (E) SUBSTANTIAL RISK NOTICE ON: Reference SEHQ ~1180-373, 374 Perfluorohexane sulfonate potassium salt Dear Sir: R3eMprroedcuecnttliyves/pDoenvseolroepdmaennt"aOlraTlox(iGcaivtaygSec)reCeonmibnignTeedstR"eSpteuadtyedofDpoesreflTuooxriocihteyxawniethsutlhfeonate Lpaobtoarsastiourmiessa,ltH(oPrsHhSa)m,, TP-e7n7n0s6y.lvTanhiea.stuTdhyewparselciomnidnuacrtyeddraafttArregsuusltReisncelaurdceh cCehratrailnesfiRnidvienrgs that appear appropriate for TSCA section 8(e) submission.

TAFT, STETTINIUS & HOLLISTER LLP comin NTIS fo 4754 425 WALNUT STREET, SUITE 1800 anim.

cond EE ii N cerApp RsoelsnrengeasA.nsBeasoisrne TAFT, STETT'NIUS & HOLLISTER LLP 425WALNUT STREET, SUITE 1800 CINCINNATI, OHIO 45202-3957 aol Fe --es--se--s November 6, 2002 a, AR226 -- 1169 I.

AR226 _ 1214 [ 7 -- -- | TSCA NCIC NOTIFICATION FORM FOR CBI DOCUMENTS |-- . -- ra DOCKET NUMBER: RR 226 DOCUMENT CONTROL NUMBER: C303 os00003 DOCUMENT DATE: R-(0-03 DOCUMENT Type: ___ Doctt F g 3 3] 2 32 z Gm Zzz So & T(CHBEI)DOUCNUDEMRENSTECRTEIFOENRE1N4COEFDTAHBEOVTOEXIISCCSLUABIMSETDANACSECSONCFOINDTERNTOILALACBTUS(ITNSECSAS).INFTOHRAMTASTEICOTNION OTFSCTAS,CAANRDEIQTUIIMRPEOSSEESPACRITMOIPNARLOTPEENCATLFTRIEOSMFPOURBLTIHCEDKINSOCWLOISNUGRAENSDCWBIILOLBFUTLAIUNNEADUTUHNODREIZRED.

4p a Sw!

2 May 2008 To[: TT -- 1UE2.PS0.A0 EEPneavninrso(ynlVmvieatnntiCaaolAkvPeeron4tu0eec0,ti8NopnWAgency Ig= ox WashingtoDnC, 20460 5. 3S8R From: Katie Smythe, onbehalfof the Telomer Research Program Ez 3353 Subject: TRP Document Submission g= c0S00o01me2mb1ondTlheyeksetnthhhsoeeuwTEmnePmslaAoa5mfr.oe2irrlTsRneeeosomfefoerrorcshtBuiPinArelAoscgdocrhomaonmlid(u(nTcCRtiiPes)dC,tftHhoLeRhCeelcHooLTrwORiNSEnh)oegrTsCooasadotseun mmamaa0rik sshe .h dies hve aheabeedn Submined 1h ts Ha 21)) 3 PI8nu2rviTiiveedR2alMoBAilcAemrlhocoeonlha:olrleS:naAAmcvoeynOlraalE/.TcroilciityMaFliixaend Aska witha Contrasroyy Dose Method Mictosome Reverse Muon 4) $) PS AhydsciocucaslCShuaelbnmidiVtsaytpb yooPfrro8P.p3eeiorstimreesey3orf e83.p. 2oATrceseo)hmesrs Alcohol Function Ula ofp Spectre TW1moeesnwltomdusdadopdacokpeirtrn1sgcis vlhoinntggeWsithhesrushispuehmermbtarnyPslnsdoefeIlhmtrSionnl ep1ogpr anee updedr otsnin Y(NoCouBnIhooufnntdhaeenytTdaSCcuAh.eid lPseissopcsoennetitanimgneiknfnwoorwemasitficoonuclhaaivmeeda a gCoenfitdesntioalmrBunsipnmesosrfomramtatiioonn Besregan, TRE Admimsor 1

Primary Sin Irritation Test wien 3071 n Mbino Rabbits Experiment o.: Conducted At: iViaa conducted By: | JUL 201983 o70e0195 Revievad By: oseazmo0ts SRiakfeertyLaEbvoarlautaotriioens,LabIoncr.atory Se.